Rebecca C Klein1, Shawn K Acheson2, Brian E Mace3, Patrick M Sullivan3, Scott D Moore4. 1. Department of Psychiatry, Duke University Medical Center, Durham, NC, USA; MIRECC, Durham Veterans Affairs Medical Center, Durham, NC, USA. 2. Department of Psychiatry, Duke University Medical Center, Durham, NC, USA; Neurobiology Research Lab, Durham Veterans Affairs Medical Center, Durham, NC, USA. 3. GRECC, Durham Veterans Affairs Medical Center, Durham, NC, USA; Department of Medicine (Geriatrics), Duke University Medical Center, Durham, NC, USA. 4. Department of Psychiatry, Duke University Medical Center, Durham, NC, USA; MIRECC, Durham Veterans Affairs Medical Center, Durham, NC, USA. Electronic address: sdmoore@duke.edu.
Abstract
The human APOE4 allele is associated with an early age of onset and increased risk of Alzheimer's disease (AD). Apolipoprotein E is secreted as part of a high-density lipoprotein-like particle by glial cells in the brain for the primary purpose of transport of lipophilic compounds involved in the maintenance of synapses. Previous studies examining synaptic integrity in the amygdala of human apoE targeted replacement (TR) mice showed a decrease in spontaneous excitatory synaptic activity, dendritic arbor, and spine density associated with apoE4 compared with apoE3 and apoE2 in adult male mice. In the present study, we assessed how APOE genotype affects synaptic integrity of amygdala neurons by comparing electrophysiological and morphometric properties in human apoE3, E4, and E2/4 TR mice at the age of 18-20 months. In contrast to adult mice, we found that aged apoE4 TR mice exhibited the highest level of excitatory synaptic activity compared with other cohorts. Additionally, apoE4 mice had significantly greater spontaneous inhibitory activity than all other cohorts. Taken together, there was a significant interaction between genotypes when comparing inhibition relative to excitation; there was a simple main effect of frequency type with an imbalance toward inhibition in apoE4 mice but not in apoE3 or apoE2/4 mice. These results suggest that apoE isoforms differentially influence synaptic transmission throughout the life span, where aging coupled with apoE4 expression, results in an imbalance in maintaining integrity of synaptic transmission. Published by Elsevier Inc.
The humanpan class="Gene">APOE4 allele is associated with an early age of onset and increased risk of Alzheimer's disease (AD). Apolipoprotein E is secreted as part of a high-density lipoprotein-like particle by glial cells in the brain for the primary purpose of transport of lipophilic compounds involved in the maintenance of synapses. Previous studies examining synaptic integrity in the amygdala of humanapoE targeted replacement (TR) mice showed a decrease in spontaneous excitatory synaptic activity, dendritic arbor, and spine density associated with apoE4 compared with apoE3 and apoE2 in adult male mice. In the present study, we assessed how APOE genotype affects synaptic integrity of amygdala neurons by comparing electrophysiological and morphometric properties in humanapoE3, E4, and E2/4 TR mice at the age of 18-20 months. In contrast to adult mice, we found that aged apoE4 TR mice exhibited the highest level of excitatory synaptic activity compared with other cohorts. Additionally, apoE4mice had significantly greater spontaneous inhibitory activity than all other cohorts. Taken together, there was a significant interaction between genotypes when comparing inhibition relative to excitation; there was a simple main effect of frequency type with an imbalance toward inhibition in apoE4mice but not in apoE3 or apoE2/4 mice. These results suggest that apoE isoforms differentially influence synaptic transmission throughout the life span, where aging coupled with apoE4 expression, results in an imbalance in maintaining integrity of synaptic transmission. Published by Elsevier Inc.
Authors: R D Terry; E Masliah; D P Salmon; N Butters; R DeTeresa; R Hill; L A Hansen; R Katzman Journal: Ann Neurol Date: 1991-10 Impact factor: 10.422
Authors: P M Sullivan; H Mezdour; Y Aratani; C Knouff; J Najib; R L Reddick; S H Quarfordt; N Maeda Journal: J Biol Chem Date: 1997-07-18 Impact factor: 5.157
Authors: Mary M Machulda; David T Jones; Prashanthi Vemuri; Eric McDade; Ramesh Avula; Scott Przybelski; Brad F Boeve; David S Knopman; Ronald C Petersen; Clifford R Jack Journal: Arch Neurol Date: 2011-05-09
Authors: Chunsheng Wang; Wilkie A Wilson; Scott D Moore; Brian E Mace; Nobuyo Maeda; Donald E Schmechel; Patrick M Sullivan Journal: Neurobiol Dis Date: 2005-03 Impact factor: 5.996
Authors: Kathryn E Simmons; Kati L Healey; Qiang Li; Scott D Moore; Rebecca C Klein Journal: Alcohol Clin Exp Res Date: 2021-10-04 Impact factor: 3.455
Authors: Tal Nuriel; Sergio L Angulo; Usman Khan; Archana Ashok; Qiuying Chen; Helen Y Figueroa; Sheina Emrani; Li Liu; Mathieu Herman; Geoffrey Barrett; Valerie Savage; Luna Buitrago; Efrain Cepeda-Prado; Christine Fung; Eliana Goldberg; Steven S Gross; S Abid Hussaini; Herman Moreno; Scott A Small; Karen E Duff Journal: Nat Commun Date: 2017-11-13 Impact factor: 14.919
Authors: Jennifer Blaze; Inbae Choi; Zhaoyu Wang; Michelle Umali; Natalia Mendelev; Anna E Tschiffely; Stephen T Ahlers; Gregory A Elder; Yongchao Ge; Fatemeh Haghighi Journal: Front Behav Neurosci Date: 2020-09-30 Impact factor: 3.558